Le Lézard
Classified in: Health, Business
Subjects: NPT, VEN, TRI

American Brain Tumor Association Awards 17 Research Grants


CHICAGO, Nov. 16, 2021 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $427,000 towards 17 new 2021 research grants to improve brain tumor science and discovery. With more than $33.5 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing treatments and ushering in the next generation of brain tumor researchers.

This year's slate of research projects investigates the use of biomarkers, imaging, experimental therapeutics, and immunotherapy for adult and pediatric brain tumors.

"These innovative new projects driven by very talented researchers instills great hope that better treatment options are within reach," said Nicole Willmarth, PhD, chief mission officer, ABTA.

Willmarth says the ABTA can invest in critical research thanks to generous support from donors and partners including Southeastern Brain Tumor Foundation, Uncle Kory Foundation and its newest partner, BrainUp.

"Persistence and funding are key to accelerating brain tumor research. Brain tumor research has been severely underfunded by the U.S. government, impeding progress to combat a ruthless and often deadly disease. I'm proud of the ABTA's tireless commitment to its mission of funding research that will one day lead to cures," Willmarth said.

The ABTA congratulates the 2021 grant recipients listed below. To learn more about the grant recipients and their research projects, visit www.abta.org/research/research-funding-impact/.

Discovery Grants are one-year, $50,000 grants supporting cutting-edge, innovative approaches that hold potential to change current diagnostic or treatment standards of care for either adult or pediatric brain tumors.

Medical Student Summer Fellowships are three-month, $3,000 grants awarded to medical students to conduct brain tumor research projects under the guidance of neuro-oncology experts. Through these grants, the ABTA seeks to encourage physician-scientists to enter and remain in the brain tumor field.

The ABTA is now accepting applications for its 2022 Discovery Grants, Basic Research Fellowships, and Jack and Fay Netchin Medical Student Summer Fellowships. For more information on grant opportunities and deadlines, visit www.ABTA.org/grants/.

About the American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association provides comprehensive resources to support the complex needs of brain tumor patients and caregivers, across all ages and tumor types, as well as the critical funding of research in pursuit of breakthroughs in brain tumor diagnoses, treatments, and care. To learn more, visit ABTA.org or call 1-800-886-ABTA (2282).

SOURCE American Brain Tumor Association


These press releases may also interest you

at 13:45
EARTHDAY.ORG, the global force behind Earth Day, is partnering with the Out of Home Advertising Association of America (OAAA), the leading trade group representing the entire out of home (OOH) advertising industry,  for the sixth year in a row! OAAA...

at 13:34
Therapist Cara Behan LMFT, launches Yoga & Meditation Membership in effort to address growing mental health crisis and need for accessible care in communities across California. A Licensed Marriage and Family Therapist, certified yoga teacher, and...

at 13:30
A new study by surgeon-scientists at Hospital for Special Surgery (HSS) found that 25% of patients with hip impingement who underwent modern arthroscopy for their condition experienced a delay in the natural progression of osteoarthritis. The...

at 13:00
Starting next week, the Network of National Library of Medicine and Columbus Metropolitan Library in Columbus, OH will host the All of Us Journey. This traveling educational exhibit brings the National Institutes of Health's All of Us Research...

at 13:00
$56.5M Equity Financing Led by Questa Capital, Laerdal Million Lives Fund, and Catalyst Health Ventures, with New Participation from RC Capital and Eckuity CapitalAvive has rapidly built an expansive and diverse customer base, delivering its FDA...

at 13:00
Lynx Dx, a leader in innovative diagnostic solutions, hailed new peer-reviewed research published today in the Journal of the American Medical Association (JAMA) Oncology that validates the efficacy of MyProstateScore 2.0 (MPS2), the company's...



News published on and distributed by: